Axxam at Bayer Co.Lab Vendor Showcase – Driving Innovation in Drug Discovery

Axxam is excited to take part in the Bayer Co.Lab Vendor Showcase 2025, an event designed to connect biotech innovators, technology providers, and pharmaceutical leaders. This showcase is a great opportunity to explore the latest advancements in early-stage drug discovery, assay development, and high-throughput screening (HTS).

Our Senior Director of Business Development will be attending to share how Axxam’s expertise in target-based screening, phenotypic assays, and compound profiling can support drug discovery efforts. With a strong focus on custom assay development, automation, and data-driven research, we help pharmaceutical and biotech companies efficiently identify and optimize new therapeutic candidates.

Axxam works across a range of therapeutic areas, including oncology, neuroscience, metabolic disorders, and rare diseases. By integrating high-content imaging, iPSC models, and functional assays, we deliver high-quality data that drives successful drug development. Our advanced screening technologies and AI-powered analytics ensure that our partners can make informed decisions at every stage of discovery.

The Bayer Co.Lab Vendor Showcase is an excellent opportunity to exchange ideas, explore collaborations, and discuss industry trends. If you’re attending, don’t miss the chance to connect with us. Let’s talk about how Axxam’s cutting-edge screening and discovery solutions can accelerate your research pipeline. Stay tuned for insights from the event as we continue to push the boundaries of innovative drug discovery!